Dextera Surgical’s MicroCutter 5/80 Highlighted in Less Invasive Lung Surgery Procedure at Society of Thoracic Surgeons 2017
January 23 2017 - 8:00AM
Business Wire
-- Lung Surgery Through a Single incision
--
Dextera Surgical Inc. (NASDAQ:DXTR), manufacturer of the
smallest-profile and most maneuverable articulating surgical
stapling platform on the market for minimally invasive surgery,
today announced that Joel Dunning, M.D, Consultant Thoracic Surgeon
at James Cook University Hospital in Middlesbrough, UK,
demonstrated how Dextera’s MicroCutter 5/80 helped enable the
removal of a lung lobe through a single small incision. The
presentation was made at The Society of Thoracic Surgeons
(STS).
“The uniportal approach to lobectomy is quickly building
momentum throughout the world as it is much less invasive than
traditional open procedures, resulting in faster patient recovery
and less pain,” said Dr. Dunning.1 “All VATS procedures, including
uniportal lobectomies, are technically challenging given the
confined space to maneuver the tools required, particularly the
limited and challenging angles of approach to the arteries and
veins. By using the MicroCutter 5/80, which articulates up to 80
degrees and has a very small surface area, I am able to
successfully complete challenging cases in a less invasive
manner.”
The uniportal lobectomy is one form of video-assisted thoracic
surgery (VATS) that uses a single two-to-three-inch incision –
either between the ribs or below the ribs in the middle of the
chest (subxiphoid) or below the ribs on one side (subcostal).
Open surgery utilizes up to an eight-inch incision while
traditional VATS lobectomy can require up to five incisions,
between individual ribs – a painful location for incisions as there
are (intercostal) nerves that run along each rib. By making just
one incision between the ribs, the uniportal lobectomy is less
invasive and less painful for the patient, which may lead to faster
recovery times and shorter hospital stays. Dr. Dunning demonstrated
how the MicroCutter 5/80 helps enable both the subxiphoid and
subcostal uniportal lobectomy as well as microlobectomy procedures
during the conference, featuring videos of the MicroCutter 5/80
stapling on a variety of pulmonary arteries and veins that would
have been more difficult with larger conventional staplers.
Currently, there are approximately 140,000 lobectomy procedures
performed each year in the U.S., with an estimated 40 percent of
those procedures using VATS techniques including uniportal,
robotic, and multiple port approaches. Leading thoracic surgeons
predict that the adoption of VATS lobectomy will continue to grow
as VATS training is integrated into residency and fellowship
programs and surgical instrumentation gets smaller and more
flexible.
“We are proud that the MicroCutter can help enable Dr. Dunning
and other leading thoracic surgeons to accelerate the transition to
VATS surgery which benefits patients undergoing these procedures,”
commented Liam Burns, Dextera’s vice president of worldwide sales
and marketing. “We continue to demonstrate that the MicroCutter is
an enabling technology for a wide variety of less invasive thoracic
procedures including uniportal lobectomy, microlobectomy, other
multiport VATS approaches.”
MicroCutter Indication Information
The MicroCutter 5/80 Stapler is manufactured and cleared for use
in the United States for transection and resection in
multiple open or minimally invasive urologic, thoracic and
pediatric surgical procedures, as well as application for
transection, resection and/or creation of anastomoses in the small
and large intestine, and the transection of the appendix. The
MicroCutter 5/80 may be used with both MicroCutter 30 White Reloads
in vascular/thin tissue and MicroCutter 30 Blue Reloads for
standard tissue.
About Dextera Surgical
Dextera Surgical (Nasdaq:DXTR) designs and manufactures
proprietary stapling devices for minimally invasive surgical
procedures. In the U.S., surgical staplers are routinely used in
more than one million minimally invasive laparoscopic,
video-assisted or robotic-assisted surgical procedures
annually.
Dextera Surgical also markets the only automated
anastomosis devices for coronary artery bypass graft (CABG) surgery
on the market today: the C-Port® Distal Anastomosis Systems and
PAS-Port® Proximal Anastomosis System. These products, sold
by Dextera Surgical under the Cardica brand name, have
demonstrated long-term reliable clinical performance for more than
a decade.
Forward-Looking Statements
The statements in this press release regarding Dextera
Surgical’s expectations for the uniportal lobectomy market and the
MicroCutter 5/80’s ability to service that market are
"forward-looking statements." There are a number of important
factors that could cause Dextera Surgical’s results to differ
materially from those indicated by these forward-looking
statements, including: surgeon demand for the MicroCutter 5/80 may
not be as much as Dextera Surgical expects due to
hospital internal policies or other factors beyond Dextera
Surgical’s control; and other risks detailed from time to time in
Dextera Surgical’s reports filed with the U.S. Securities and
Exchange Commission, including its Quarterly Report on Form 10-Q
for the quarter ended September 30, 2016, under the caption
“Risk Factors.” Dextera Surgical expressly disclaims any
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements contained herein. You
are encouraged to read Dextera Surgical’s reports filed with
the U.S. Securities and Exchange Commission, available
at www.sec.gov.
1 Dunning, J. (2016, October). Microlobectomy, A Novel Form of
VATS Lobectomy. Podium presentation at the European Association for
Cardio-Thoracic Surgery, 2016, Barcelona, Spain.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170123005316/en/
Dextera Surgical Inc.Investors:Bob Newell, 650-331-7133Vice
President, Finance and Chief Financial
Officerinvestors@dexterasurgical.comMedia:Jessica Volchok,
310-849-7985jessica@nicoleosmer.com